Morphometric study of the hepatic lesions experimentally induced in hamsters by Entamoeba Dispar and E. Histolytica

Parasite

Volumn 14, Issue 4, 2007, Pages 329-334

  Costa, C A X ^a   Brito, K N O ^a   Gomes, M A ^a   Caliari, Marcelo Vidigal ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Entamoeba dispar; Entamoeba histolytica; Hepatic necrosis; Pothogenesis

Indexed keywords

ANIMALIA; CRICETINAE; ENTAMOEBA DISPAR; ENTAMOEBA HISTOLYTICA;

ANIMAL; ANIMAL DISEASE; ARTICLE; ENTAMOEBA; ENTAMOEBA HISTOLYTICA; HAMSTER; IMMUNOHISTOCHEMISTRY; LIVER; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; VIRULENCE;

ANIMALS; CRICETINAE; ENTAMOEBA; ENTAMOEBA HISTOLYTICA; IMMUNOHISTOCHEMISTRY; LIVER; VIRULENCE;

EID: 37249051388     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: 10.1051/parasite/2007144329     Document Type: Article

References (17)

1. AGUIRRE-GARCIA M.M., ANAYA-RUIZ M. & TALAMAS-ROHANA P. Membrane-bound acid phosphatase (MAP) from Entamoeba histolytica has phosphotyrosine phosphatase activity and disrupts the actin cytoskeleton of host cells. Parasitology, 2003, 126, 195-202.
2. CALIARI M.V. Princípios Básicos de Morfometria Digital: KS300 para iniciantes. Ed. UFMG, 1997, 149 p.
3. CLARK G.G. & DIAMOND L.S. Intraspecific variation and phylogenetic relationships in the genus Entamoeba as revealed by riboprinting. Journal of Eukaryotic Microbiology, 1997, 44, 142-154.
4. COSTA A.O., VIANA J.C., ASSIS D., ROCHA O.A. & SILVA E.F. Comparation of Xenic and Monoxenic Entamoeba dispar cultures using hepatic inoculation in hamster. Archives of Medical Research, 2000, 31, S247-S248.
5. DIAMOND L.S. & CLARCK G.G. A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) Separating it from Entamoeba dispar "Brumpt, 1925. Journal of Eukaryotic Microbiology, 1993, 40, 340-344.
6. ESPINOSA-CANTELLANO M., GONZALES-R OBLES A., CHAVEZ B., CASTANON G., ARGLELLO C., LAZARO-HALLER A. & MARTINEZ-PALOMO A. Entamoeba dispar. Ultrastructure, surface properties and cytophatic effect. Journal of Eukaryotic Microbiologyi1998, 45, 265-272.
7. FURST C., GOMES M.A., TAFURI W.L. & SILVA E.F. Biological aspects of a brazilian strain of Entamoeba dispar. Pathologica, 2002, 94, 22-27.
8. GOMES M.A., PESQUERO J.B., FURST C., VALLE P.R., PESQUERO J.L. & SILVA E.F. An improved method to distinguish Entamoeba histolytica and E. dispar. Parasitology, 1999, 119, 359-362.
9. GOMES M.A., MELO M.N., MACEDO A.M., PENA G.P.M. & CALIARI M.V. Characterization of Entamoeba histolytica and Entamoeba dispar by biological, and Molecular Parameters. Archives of Medical Research, 2000, 31, S249-S250.
10. LEIPPE M., BHAR E., TANNICH E. & HORSTMANN R.D. Comparison of pore-forming peptides from pathogenic and nonpathogenic Entamoeba histolytica. Molecular and Biochemical Parasitology, 1993, 59, 101-110.
11. LOPEZ-VANCELL R., MONTFORT I. & PEREZ-TAMAYO R. Galactose-specific adhesin and cytotoxicity of Entamoeba histolytica. Parasitology Research, 2000, 86, 226-231.
12. MACFARLANE R.C., SHAH P.H. & SINGH U. Transcriptional profiling of Entamoeba histolytica trophozoites. International Journal for Parasitology, 2005, 35, 533-542.
13. MARTINEZ A.M.B., GOMES M.A., VIANA J.C., ROMANHA A.J. & SILVA E.F. Isoenzyme profile as parameter to differentiate pathogenic strains of Entamoeba histolytica in Brazil. Revista do Instituto de Medicina Tropical, 1996, 38, 407-412.
14. QUE X. & REED S.L. Cysteine proteinases and the pathogenesis of amebiasis. Clinical Microbiology Reviews, 2000, 13, 196-206.
15. RIVERO-NAVA L., AGLIRRE-GARCIA J., SHIBAYAMA-SALAS M., HERNANDEZ-PANDO R., TSUTSUMI V. & CALDERON J. Entamoeba histolytica: acute granulomatous intestinal lesions in normal and neutrophil-depleted mice. Experimental Parasitology, 2002, 101, 183-192.
16. TSUTSUMI V., MENA-LOPEZ R., ANAYA-VELAZQUEZ F. & MARTINEZ-PALOMO A. Cellular bases of the experimental amebic liver abscess formation. American Journal of Pathology, 1984, 117, 81-91.
17. ZHANG Z., MAHAJAN S., ZHANG X. & STANLEY S.L. Tumor necrosis factor alpha is a key mediator of gut inflammation seen in amebic colitis in human intestine in the SCID mouse-human intestinal xenograft model of disease. Infection and Immunity, 2003, 5355-5359.